Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Global Pharmatech, Inc. (GBLP)

Compare
0.2012
0.0000
(0.00%)
As of April 16 at 4:00:00 PM EDT. Market Open.
Loading Chart for GBLP
  • Previous Close 0.2799
  • Open 0.2799
  • Bid 0.2000 x --
  • Ask 0.2700 x --
  • Day's Range 0.2799 - 0.2799
  • 52 Week Range 0.1500 - 0.3500
  • Volume 1,000
  • Avg. Volume 501
  • Market Cap (intraday) 81.529M
  • Beta (5Y Monthly) -0.77
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Global Pharmatech, Inc., through its subsidiaries, discovers, develops, manufactures, and markets proprietary therapeutical products based on Traditional Chinese Medicine (TCM). The company was founded in 2001 and is based in Mong Kok, Hong Kong.

217

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GBLP

View More

Performance Overview: GBLP

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

GBLP
31.93%
S&P 500 (^GSPC)
9.46%

1-Year Return

GBLP
34.13%
S&P 500 (^GSPC)
6.03%

3-Year Return

GBLP
21.94%
S&P 500 (^GSPC)
21.23%

5-Year Return

GBLP
32.48%
S&P 500 (^GSPC)
85.25%

Compare To: GBLP

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GBLP

View More

Valuation Measures

Annual
As of 4/16/2025
  • Market Cap

    81.53M

  • Enterprise Value

    81.53M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -70.45%

  • Return on Assets (ttm)

    -10.39%

  • Return on Equity (ttm)

    -22.59%

  • Revenue (ttm)

    3.18M

  • Net Income Avi to Common (ttm)

    -2.24M

  • Diluted EPS (ttm)

    -0.3000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.44M

  • Total Debt/Equity (mrq)

    28.58%

  • Levered Free Cash Flow (ttm)

    325.78k

Research Analysis: GBLP

View More

Company Insights: GBLP

Research Reports: GBLP

View More

People Also Watch